Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|17|2|188-197

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.17, Iss.2, 2015-02, pp. : 188-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of remifentanil on esophageal motility: a double‐blind, randomized, cross‐over study in healthy volunteers

By  

ACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol. 59, Iss. 9, 2015-10 ,pp. : 1126-1136

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine‐resistant vernal keratoconjunctivitis: A randomized, comparative, double‐blind, crossover study

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 3, 2015-05 ,pp. : 256-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differences between observers in interpreting double‐blind placebo‐controlled food challenges: A randomized trial

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 25, Iss. 8, 2014-12 ,pp. : 755-759

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double‐blind placebo‐controlled 102‐week trial

By  

DIABETIC MEDICINE, Vol. 32, Iss. 4, 2015-04 ,pp. : 531-541

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 453-457

John Wiley & Sons Inc

Access to resources Recommend Favorite